✦ LIBER ✦

Short-term efficacy of chimeric monoclonal antibody cA2 to tumor necrosis factor α for refractory, fistulizing Crohn's disease

✍ Scribed by S. Bollani; S. Ardizzone; E. Colombo; V. Imbesi; G. Bianchi Porro

Book ID: 119629601
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 153 KB
Volume: 32
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(00)80180-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Short-term efficacy of chimeric monoclon

Short-term efficacy of chimeric monoclonal antibody cA2 to tumor necrosis factor a for refractory, fistulizing Crohn's disease

✍ Ardizzone, Sandra; Bollani, Simona; Colombo, Elisabetta; Imbesi, Venerina; Bianc 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 191 KB

A Short-Term Study of Chimeric Monoclona

A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

✍ Targan, Stephan R.; Hanauer, Stephen B.; van Deventer, Sander J.H.; Mayer, Lloyd 📂 Article 📅 1997 🏛 Massachusetts Medical Society 🌐 English ⚖ 105 KB

Mechanism and Therapeutic Strategy of Se

Mechanism and Therapeutic Strategy of Secondary Failure to Anti-Tumor Necrosis Factor-a Monoclonal Antibody Treatment for Crohn's Disease

✍ Matsuoka, Katsuyoshi; Kanai, Takanori 📂 Article 📅 2013 🏛 S. Karger AG 🌐 English ⚖ 97 KB

P371 Short- and long-term efficacy of in

P371 Short- and long-term efficacy of infliximab in intestinal Behcet's disease refractory to conventional medications indicates a major role for tumour necrosis factor-alpha

✍ Kinoshita, H.; Kunisaki, R.; Tomohiko, S.; Kimura, H.; Maeda, S. 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 51 KB

Unexpected dramatic clinical response of

Unexpected dramatic clinical response of psoriasis lesions and unexpected pregnancy in an infertile patient in response to treatment with anti-tumor necrosis factor (tnfalpha) monoclonal antibody for Crohn’s Disease

✍ Leslie Bank∗; Belinda Hunt 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 24 KB

The effect of monoclonal anti-tumor necr

The effect of monoclonal anti-tumor necrosis factor-antibody cA2 on coagulation- and fibrinolytic parameters in patients with active Crohn's disease: D.W. Hommes, H.M. van Dullemen, J. Meenan, A. van den Ende, J. Woody, G.N.J. Tytgat, S.J.H. van Deventer. Center for Thrombosis, Hemostasis, Atherosclerosis and Inflammation Research, Dept. of Gastroenterology, University of Amsterdam, Amsterdam, the Netherlands

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 177 KB